-transparent.png){kind=logo}
Six post-menopausal women were submitted, at 1 month interval, to oral oestriol treatment for 14-day periods at daily doses of 2 and 6 mg. Blood samples were collected for LH, FSH and PRL measurements (by RIA) every other day during treatments as well as during a 14-day control period. Through the effect on LH levels was questionable, oestriol resulted in a clear and significant, although moderate, gradual decrease of mean FSH levels. At the doses used, which are effective in thetreatment of menopausal symptoms, but are devoid of any proliferative effect upon the endometrium, oestriol failed to induce any stimulatory effect on basal PRL secretion in these post-menopausal women.
M L'Hermite, and
M M Badawi, and
A Michaux-Duchene, and
C Robyn
March 1981,
Maturitas,
M L'Hermite, and
M M Badawi, and
A Michaux-Duchene, and
C Robyn
February 1980,
The Journal of clinical endocrinology and metabolism,
M L'Hermite, and
M M Badawi, and
A Michaux-Duchene, and
C Robyn
August 1982,
Maturitas,
M L'Hermite, and
M M Badawi, and
A Michaux-Duchene, and
C Robyn
October 1991,
Maturitas,
M L'Hermite, and
M M Badawi, and
A Michaux-Duchene, and
C Robyn
June 1991,
Maturitas,
M L'Hermite, and
M M Badawi, and
A Michaux-Duchene, and
C Robyn
January 2002,
Journal of endocrinological investigation,
M L'Hermite, and
M M Badawi, and
A Michaux-Duchene, and
C Robyn
January 1997,
Journal of the Society for Gynecologic Investigation,
M L'Hermite, and
M M Badawi, and
A Michaux-Duchene, and
C Robyn
July 1986,
Maturitas,
M L'Hermite, and
M M Badawi, and
A Michaux-Duchene, and
C Robyn
June 1989,
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
M L'Hermite, and
M M Badawi, and
A Michaux-Duchene, and
C Robyn
May 1982,
Medicina clinica,
